Back to search

Article

Automating neoantigen selection for personalized cancer vaccine design

2026-07-01

Abstract excerpt

Advancements in immunogenomics and immuno-oncology have enabled the development of personalized cancer vaccines (PCVs) that target cancer cell-specific somatic variants. A subset of these variants produce neoantigens that, when presented on tumor cells by MHC molecules, have the potential to elicit a robust and specific immune response. To date, there are over one hundred interventional studies listed on clinical...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
11caf38f-bd37-588a-8e42-a8d46c67053e
DOI
10.64898/2026.06.24.26356293
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Automating neoantigen selection for personalized cancer vaccine designDOI 10.64898/2026.06.24.26356293
Select a neighboring publication to make it the new centre.